Cervical cancer (CC) is one of the most prevalent malignancies in females worldwide, in which one of its major causative agents is human papillomavirus type 16 (HPV16). The current HPV screening measures are responsible for reducing CC incidence; however, some limitations still persist which brings about the necessity to investigate novel biomarkers. The HPV16 genome contains several genes with…
Cervical cancer is included in the fourth list of most common cancer among women worldwide and the second top cancer among women in Indonesia. However, the available method to fight this cancer is only prevention, such as screening and prophylactic vaccination. As most cases arise from women who have not gotten HPV vaccination, developing a therapeutic vaccine is essential. Most of the case…